CL•October 30, 2026 at 10:55 AM UTCHousehold & Personal Products

Colgate Q3 2026: Organic Sales Up 3.6%, Margin Expansion, EPS Beat

Read source article

What happened

Colgate-Palmolive reported third quarter 2026 results with net sales rising 4.6% and organic sales up 3.6%, including a 0.2% drag from lower private label pet food sales. GAAP EPS increased 3% to $0.94, while base business EPS rose 7% to $0.97, indicating solid underlying profitability. Gross margin expanded 80 basis points to 60.2% on a GAAP basis and 90 basis points to 60.3% on a base business basis, reflecting effective cost management. Net cash provided by operations reached $2,913 million for the first nine months of 2026, underscoring robust cash generation. These results mark an improvement from Q2 2025, when sales grew just 1% with flat volume and North American margin pressure, suggesting the company is successfully navigating prior headwinds.

Implication

The 3.6% organic sales growth and gross margin expansion directly address two watch items from the prior report: stalled volume and regional margin compression. While private label pet food continues to subtract from growth, the overall trend is positive and suggests core brand strength. The strong operating cash flow of $2.9 billion over nine months supports the company's ability to fund dividends and buybacks without stress. However, at a P/E above 21 and trading above the base-case DCF of $65.46, the market already prices in much of this improvement. Therefore, while the operational outlook has improved modestly, the risk/reward remains balanced, and we maintain a HOLD rating pending further evidence of sustainable volume growth and margin gains.

Thesis delta

The thesis shifts slightly positive on operations: Q3 2026 shows stronger organic growth and margin expansion than the prior report's near-term outlook, easing concerns about stagnation. However, the private label pet food drag remains a minor headwind, and the stock's valuation above DCF still lacks margin of safety. Consequently, the HOLD judgment is maintained, though the basis shifts from valuation-constrained to a more balanced view with improved fundamental momentum.

Confidence

Medium